Helen Sabzevari, President and CEO at PRECIGEN, INC. (PGEN), sold 3,848 shares at $3.67 ($14K) on 2022-01-03, disclosed to the SEC on 2022-01-04.
Scheduled sale ($14k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| PGEN | SELL | 2023-08-25 | $236K | — | Filing → |
| PGEN | SELL | 2023-08-18 | $185K | — | Filing → |
| PGEN | SELL | 2023-08-11 | $119K | — | Filing → |